Portal:CPTAC

From WikiPathways
Jump to: navigation, search

edit  

CPTAC Pathways

Welcome to the CPTAC Pathway Portal

This portal highlights pathway content relevant to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).

The National Cancer Institute, part of the National Institutes of Health, announced the launch of a Clinical Proteomic Tumor Analysis Consortium in August 2011. CPTAC is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust, quantitative, proteomic technologies and workflows. The overarching goal of CPTAC is to improve our ability to diagnose, treat and prevent cancer. To achieve this goal in a scientifically rigorous manner, the NCI launched CPTAC to systematically identify proteins that derive from alterations in cancer genomes and related biological processes, and provide this data with accompanying assays and protocols to the public.

CPTAC-logo.png

edit  

Cancer Hallmark Categories

Sustaining proliferative signaling ErbB Signaling Pathway (Homo sapiens)
ErbB Signaling Pathway
Evading growth suppressors TGF-beta Receptor Signaling (Homo sapiens)
TGF-beta Receptor Signaling
Activating invasion and metastasis MFAP5-mediated ovarian cancer cell motility and invasiveness (Homo sapiens)
MFAP5-mediated ovarian cancer cell motility and invasiveness
Enabling replicative immortality Wnt/beta-catenin Signaling Pathway in Leukemia (Homo sapiens)
Wnt/beta-catenin Signaling Pathway in Leukemia
Inducing angiogenesis Angiogenesis (Homo sapiens)
Angiogenesis
Resisting cell death miRNA regulation of p53 pathway in prostate cancer (Homo sapiens)
miRNA regulation of p53 pathway in prostate cancer
Deregulating cellular energetics Fatty Acid Beta Oxidation (Homo sapiens)
Fatty Acid Beta Oxidation
Genome instability and mutation Non-homologous end joining (Homo sapiens)
Non-homologous end joining
Tumor promoting inflammation Cytokines and Inflammatory Response (Homo sapiens)
Cytokines and Inflammatory Response
Avoiding immune destruction Type II interferon signaling (IFNG) (Homo sapiens)
Type II interferon signaling (IFNG)
Therapeutics LncRNA-mediated mechanisms of therapeutic resistance (Homo sapiens)
LncRNA-mediated mechanisms of therapeutic resistance

edit  

Featured Pathways

edit  

Pathway Curation

On this page you see rotating displays of hallmark and featured pathways. Where did these pathways come from? They came from people like you! The CPTAC set of pathways can be edited, fixed and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Resources

Curation projects

edit  

Useful Links